Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118335922 | 11833592 | 2 | F | 20160628 | 20151214 | 20160712 | EXP | US-TEVA-617516USA | TEVA | GOLOMB B. FLUOROQUINOLONE-INDUCED SERIOUS, PERSISTENT, MULTISYMPTOM ADVERSE EFFECTS.. BMJ-CASE-REP. 2016 JUN 28;. | 55.00 | YR | F | Y | 0.00000 | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118335922 | 11833592 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 500 MG/DAY FOR 10 DAYS (3 COURSES) | 76361 | ||||||||||
| 118335922 | 11833592 | 2 | SS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 750 MG FOR 5 DAYS | 76361 | ||||||||||
| 118335922 | 11833592 | 3 | C | alendronic acid | ALENDRONIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118335922 | 11833592 | 1 | Urinary tract infection |
| 118335922 | 11833592 | 2 | Sinusitis |
| 118335922 | 11833592 | 3 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118335922 | 11833592 | OT |
| 118335922 | 11833592 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118335922 | 11833592 | Affective disorder | |
| 118335922 | 11833592 | Alopecia | |
| 118335922 | 11833592 | Amnesia | |
| 118335922 | 11833592 | Anxiety | |
| 118335922 | 11833592 | Arthralgia | |
| 118335922 | 11833592 | Cardiovascular disorder | |
| 118335922 | 11833592 | Cognitive disorder | |
| 118335922 | 11833592 | Confusional state | |
| 118335922 | 11833592 | Fatigue | |
| 118335922 | 11833592 | Headache | |
| 118335922 | 11833592 | Hypoacusis | |
| 118335922 | 11833592 | Mental disorder | |
| 118335922 | 11833592 | Muscular weakness | |
| 118335922 | 11833592 | Myalgia | |
| 118335922 | 11833592 | Neuropathy peripheral | |
| 118335922 | 11833592 | Pain | |
| 118335922 | 11833592 | Sensory disturbance | |
| 118335922 | 11833592 | Sleep disorder | |
| 118335922 | 11833592 | Tendon disorder | |
| 118335922 | 11833592 | Tinnitus | |
| 118335922 | 11833592 | Toxicity to various agents | |
| 118335922 | 11833592 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |